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Objectives
To develop a model for determining the level of dose
adherence of Antiretroviral Therapy (ART) clients from
the first day of ART to the day of interview and to
determine the dose adherence levels of the ART clients
using the model.
Methods
A cross-sectional study was conducted using pre-tested
standardized questionnaires in exitinterviews in three
ART centres and eleven social support groups to
determine the dose adherence levels of ART clients in
the Eastern Region of Ghana. A dose-adherence model
was developed from three types of dose records; the
observed doses, the expected doses and the missed
doses and the frequency at which clients defaulted
since commencement of ART. This model encapsu-
lated the short-term recall of missed doses and the
long-term default frequency of ART clients to arrive at
the observed / expected adherence level ratio; the
expected doses being the theoretical number of doses
to be taken from the first day of ART to the time of
interview and the observed doses being the difference
between the expected doses and the missed doses.
Results
Standard adherence levels derived from the model based
on literature were 25% [1], 50% [2], 80% [3] and 100%
[4]. However, 83.2% of respondents were 100% adherent
having honoured all their re-fill appointments and never
missed doses since commencement of ART. 14% and
1.7% of the 725 respondents were 80% and 50% adher-
ent respectively whereas the remaining 1.1 % were 25%
adherent. Observed adherence levels were statistically
significant at a p-value of 0.0517. Further analyses on
factors affecting dose adherence were conducted on the
respondent’s knowledge, attitudes and practices, socio-
demographic features, social support received, ARV dis-
pensing consistency and sources of ART information
and there was no significance over the adherence levels.
Contrarily, the mechanisms adopted for adherence sig-
nificantly (p-value = 0.0517) affected the adherence
levels.
Conclusion
The dose-adherence model complements other methods
for deducing client’s level of dose adherence by consid-
ering the long-term default frequency as an addition to
the short-term recall of missed doses or self-report.
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